Monte Rosa Therapeutics, Inc. 10,638,476 Shares of Common Stock And Pre-Funded Warrants to Purchase 10,638,524 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 16th, 2024 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 16th, 2024 Company Industry Jurisdiction